Selected article for: "ad disease and ad potential"

Author: Soares, Alberto Carpinteiro; Ferreira, Andreia; Mariën, Jonas; Delay, Charlotte; Lee, Edward; Trojanowski, John Q.; Moechars, Dieder; Annaert, Wim; De Muynck, Louis
Title: PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
  • Cord-id: 03ft2cch
  • Document date: 2021_4_6
  • ID: 03ft2cch
    Snippet: Tauopathies, such as Alzheimer's disease (AD), are neurodegenerative disorders characterized by the deposition of hyperphosphorylated tau aggregates. Proteopathic tau seeds spread through the brain in a temporospatial pattern, indicative of transsynaptic propagation. It is hypothesized that reducing the uptake of tau seeds and subsequent induction of tau aggregation could be a potential approach for abrogating disease progression in AD. Here, we studied to what extent different endosomal routes
    Document: Tauopathies, such as Alzheimer's disease (AD), are neurodegenerative disorders characterized by the deposition of hyperphosphorylated tau aggregates. Proteopathic tau seeds spread through the brain in a temporospatial pattern, indicative of transsynaptic propagation. It is hypothesized that reducing the uptake of tau seeds and subsequent induction of tau aggregation could be a potential approach for abrogating disease progression in AD. Here, we studied to what extent different endosomal routes play a role in the neuronal uptake of preformed tau seeds. Using pharmacological and genetic tools, we identified dynamin-1, actin, and Rac1 as key players. Furthermore, inhibition of PIKfyve, a protein downstream of Rac1, reduced both the trafficking of tau seeds into lysosomes and the induction of tau aggregation. Our work shows that tau aggregates are internalized by a specific endocytic mechanism and that their fate once internalized can be pharmacologically modulated to reduce tau seeding in neurons.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1